ADTX Quote, Financials, Valuation and Earnings

Electromed, Inc. has a net margin of -3458242.86% compared to Aditxt, Inc.'s net margin of 12.65%. Aditxt, Inc.'s return on equity of -681.25% beat Electromed, Inc.'s return on equity of 18.89%.

Aditxt, Inc. has a consensus price target of --, signalling upside risk potential of 897058723.53%. On the other hand Electromed, Inc. has an analysts' consensus of $36.00 which suggests that it could grow by 26.32%. Given that Aditxt, Inc. has higher upside potential than Electromed, Inc., analysts believe Aditxt, Inc. is more attractive than Electromed, Inc..

Aditxt, Inc. has a beta of 1.264, which suggesting that the stock is 26.35% more volatile than S&P 500. In comparison Electromed, Inc. has a beta of 0.259, suggesting its less volatile than the S&P 500 by 74.113%.

Aditxt, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aditxt, Inc. pays -- of its earnings as a dividend. Electromed, Inc. pays out -- of its earnings as a dividend.

Aditxt, Inc. quarterly revenues are $700, which are smaller than Electromed, Inc. quarterly revenues of $16.9M. Aditxt, Inc.'s net income of -$24.2M is lower than Electromed, Inc.'s net income of $2.1M. Notably, Aditxt, Inc.'s price-to-earnings ratio is -- while Electromed, Inc.'s PE ratio is 30.66x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aditxt, Inc. is 36.41x versus 3.80x for Electromed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Pulmonx Corp. has a net margin of -3458242.86% compared to Aditxt, Inc.'s net margin of -64.91%. Aditxt, Inc.'s return on equity of -681.25% beat Pulmonx Corp.'s return on equity of -73.42%.

Aditxt, Inc. has a consensus price target of --, signalling upside risk potential of 897058723.53%. On the other hand Pulmonx Corp. has an analysts' consensus of $5.75 which suggests that it could grow by 159.01%. Given that Aditxt, Inc. has higher upside potential than Pulmonx Corp., analysts believe Aditxt, Inc. is more attractive than Pulmonx Corp..

Aditxt, Inc. has a beta of 1.264, which suggesting that the stock is 26.35% more volatile than S&P 500. In comparison Pulmonx Corp. has a beta of 0.219, suggesting its less volatile than the S&P 500 by 78.135%.

Aditxt, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pulmonx Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aditxt, Inc. pays -- of its earnings as a dividend. Pulmonx Corp. pays out -- of its earnings as a dividend.

Aditxt, Inc. quarterly revenues are $700, which are smaller than Pulmonx Corp. quarterly revenues of $21.5M. Aditxt, Inc.'s net income of -$24.2M is lower than Pulmonx Corp.'s net income of -$14M. Notably, Aditxt, Inc.'s price-to-earnings ratio is -- while Pulmonx Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aditxt, Inc. is 36.41x versus 0.97x for Pulmonx Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Quantum-Si, Inc. has a net margin of -3458242.86% compared to Aditxt, Inc.'s net margin of -6467.94%. Aditxt, Inc.'s return on equity of -681.25% beat Quantum-Si, Inc.'s return on equity of -51.75%.

Aditxt, Inc. has a consensus price target of --, signalling upside risk potential of 897058723.53%. On the other hand Quantum-Si, Inc. has an analysts' consensus of $2.68 which suggests that it could grow by 118.16%. Given that Aditxt, Inc. has higher upside potential than Quantum-Si, Inc., analysts believe Aditxt, Inc. is more attractive than Quantum-Si, Inc..

Aditxt, Inc. has a beta of 1.264, which suggesting that the stock is 26.35% more volatile than S&P 500. In comparison Quantum-Si, Inc. has a beta of 2.983, suggesting its more volatile than the S&P 500 by 198.267%.

Aditxt, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Quantum-Si, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aditxt, Inc. pays -- of its earnings as a dividend. Quantum-Si, Inc. pays out -- of its earnings as a dividend.

Aditxt, Inc. quarterly revenues are $700, which are smaller than Quantum-Si, Inc. quarterly revenues of $552K. Aditxt, Inc.'s net income of -$24.2M is higher than Quantum-Si, Inc.'s net income of -$35.7M. Notably, Aditxt, Inc.'s price-to-earnings ratio is -- while Quantum-Si, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aditxt, Inc. is 36.41x versus 69.81x for Quantum-Si, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings, Inc. has a net margin of -3458242.86% compared to Aditxt, Inc.'s net margin of 3.93%. Aditxt, Inc.'s return on equity of -681.25% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

Aditxt, Inc. has a consensus price target of --, signalling upside risk potential of 897058723.53%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 93.3%. Given that Aditxt, Inc. has higher upside potential than Xtant Medical Holdings, Inc., analysts believe Aditxt, Inc. is more attractive than Xtant Medical Holdings, Inc..

Aditxt, Inc. has a beta of 1.264, which suggesting that the stock is 26.35% more volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.

Aditxt, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aditxt, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

Aditxt, Inc. quarterly revenues are $700, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Aditxt, Inc.'s net income of -$24.2M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Aditxt, Inc.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 76.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aditxt, Inc. is 36.41x versus 0.85x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.